Technology
Health
Biotechnology
Zai Lab
$29.119876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$29.11
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.82 (-2.74%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell Zai Lab and other stocks, options, ETFs, and crypto commission-free!
About
Zai Lab Limited American Depositary Shares, also called Zai Lab, is a biopharmaceutical company, which engages in the licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need. Its product pipelines include ZL-2306, ZL-2401, FPA144, ETX2514, and ZL-2301. Read More The company was founded by Samantha Ying Du and Marietta Wu in 2014 and is headquartered in Shanghai, China.
Employees
88
Headquarters
Shanghai, Shanghai
Founded
2014
Market Cap
1.47B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
148.61K
High Today
$29.78
Low Today
$29.03
Open Price
$29.70
Volume
28.90K
52 Week High
$31.97
52 Week Low
$14.29
Collections
Technology
Health
Biotechnology
Biopharmaceutical
Therapy
Medical
Pharmaceutical
2017 IPO
News
Simply Wall StMar 13
Does Zai Lab’s (NASDAQ:ZLAB) Share Price Gain of 36% Match Its Business Performance?
These days it’s easy to simply buy an index fund, and your returns should (roughly) match the market. But one can do better than that by picking better than average stocks (as part of a diversified portfolio). For example, the Zai Lab Limited (NASDAQ:ZLAB) share price is up 36% in the last year, clearly besting than the market return of around 0.6% (not including dividends). If it can keep that out-performance up over the long term, investors will do very well! Zai Lab hasn’t been listed for long, so it’s s...
MarketBeatMar 1
Stock Price, News, & Analysis for Zai Lab
Zai Lab Limited, a biopharmaceutical company, engages in discovering or licensing, developing, and commercializing proprietary therapeutics that address medical needs in the fields of oncology, and autoimmune and infectious disease therapies in the People's Republic of China.
Price Paid on Robinhood
23% Higher
Right Now
52 Week Low
$14.29
Average Price Paid
$23.64
52 Week High
$31.97
Earnings
-$0.28
-$0.25
-$0.21
-$0.18
Q4 2016
Q1 2017
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Estimated
—
Actual
Expected May 1, Pre-Market